Company Overview
Health Catalyst, Inc. operates as a provider of data and analytics technology and services specifically designed for healthcare organizations within the United States. The company functions across two distinct operational segments, Technology and Professional Services, offering the ignite data and analytics platform which aims to deliver a single comprehensive environment for its clients. This entity is positioned within the broader Healthcare sector and the specialized Health Information Services industry, indicating its focus on digitizing and optimizing clinical and operational workflows. The firm employs approximately 1,200 individuals and carries a market capitalization of $80.94M, with trailing twelve-month revenue totaling $311.14M. These valuation and revenue figures suggest a company that generates significant top-line activity relative to its size, yet operates as a small-cap entity with a market value under $100 million.
Financial Health
Health Catalyst, Inc. reported total revenue of $311.14M for the trailing twelve months, though it recorded a net income loss of $177,974,000 and an EBITDA of $-5,167,000. The substantial gap between the positive revenue of $311.14M and the negative net income reveals a cost structure where operating expenses, including potentially high customer acquisition or implementation costs, significantly erode profitability. Despite the reported net loss, the company generated positive free cash flow of $10.73M, which provides a degree of financial flexibility by allowing the firm to fund operations or strategic initiatives without immediate reliance on external equity financing. The company's margins reflect this financial pressure, with a gross margin of 49.7%, an operating margin of -4.3%, and a profit margin of -57.2%. While the gross margin indicates that the core product or service delivery retains nearly half of its revenue, the negative operating and profit margins demonstrate that overhead costs and operating expenses are exceeding gross profits. On the balance sheet, Health Catalyst holds $95.73M in cash against $171.24M in debt, resulting in a debt-to-equity ratio of 69.67, which characterizes a highly leveraged position where debt obligations substantially outweigh equity. The current ratio stands at 1.89, indicating that the company possesses sufficient current assets to cover its short-term liabilities nearly twice over, suggesting adequate short-term liquidity. Return on equity is reported at -58.3% and return on assets at -4.0%, metrics that collectively reveal that management has not yet achieved positive returns on the capital invested or the assets deployed to generate revenue.
Valuation Assessment
The valuation metrics present a stark contrast between historical performance and future expectations, with a trailing P/E ratio of N/A due to the lack of earnings and a forward P/E of 5.06. This divergence implies that the market is pricing the stock based on anticipated future earnings rather than past performance, suggesting high expectations for a turnaround in profitability. The price-to-book ratio is 0.32, indicating that the market values the company at less than one-third of its book value, which typically suggests the stock is trading at a significant discount relative to its tangible asset base. Additionally, the price-to-sales ratio is 0.26 and the EV/EBITDA is -30.28, further reinforcing that traditional valuation multiples are distorted by the company's current negative earnings position. The stock has traded within a range defined by a 52-week high of $5.06 and a 52-week low of $1.04, meaning the current price sits significantly closer to the low end of this historical range. The beta value is 1.78, which indicates that the stock price is expected to be nearly twice as volatile as the broader market, exposing investors to higher fluctuations in price.
Growth & Income
Revenue growth for the year-over-year period stands at -6.2%, while earnings growth is N/A due to the negative earnings baseline. Since there is no positive earnings growth to compare against revenue decline, the company is currently experiencing a contraction in both top-line sales and profitability simultaneously. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute cash to shareholders but instead retains all earnings to fund operations and potential future growth. Consequently, the overall growth and income profile for Health Catalyst, Inc. is currently defined by negative revenue growth and a lack of dividend income, relying entirely on operational performance improvements to restore profitability and potentially support shareholder returns in the future.